ELAN logo

ELAN Stock Overview

Profile

Full Name:

Elanco Animal Health Incorporated

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Country:

United States

IPO:

September 20, 2018

Indexes:

Not included

Website:

http://www.elanco.com

Description:

Elanco Animal Health Incorporated is a pharmaceutical company that develops and markets products for the treatment of animals. The Prevention of diseases in domestic animals segment includes a wide range of parasiticides. The Therapy for domestic animals segment provides means and services for pain and osteoarthritis treatment, with different modes of action, indications, and disease stages. The Protein and Health segment includes vaccines, food enzymes, and antibiotics for animals. The Ruminant and Swine category segment is engaged in the development of vaccines, antibiotics, implants, parasiticides, and animal origin products widely used in the breeding of ruminant animals. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Key Details

Price

$11.22

Market Cap

$5.55 B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$4.44 B(+0.50% YoY)

Annual EPS

$0.68(+127.20% YoY)

PE Ratio

16.75

Annual ROE

5.49%

Annual Debt To Equity

0.71

Beta

1.07

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Feb 25, 2025

Recent annual earnings:

Feb 25, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 26, 25 UBS
Buy
Feb 26, 25 Stifel
Buy
Feb 26, 25 Morgan Stanley
Equal-Weight
Feb 26, 25 Barclays
Overweight
Feb 21, 25 Stifel
Buy
Jan 29, 25 Morgan Stanley
Equal-Weight
Jan 7, 25 Stifel
Buy
Dec 9, 24 UBS
Buy
Dec 2, 24 Leerink Partners
Market Perform
Nov 8, 24 Barclays
Overweight

Screeners with ELAN included

Growing Shares Outstanding
Mid cap stocks
US stocks
Stocks with high beta
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
Specialty & Generic Drug Manufacturers industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$11.22
ELAN price is $11.22

Price All-time High

$36.72
ELAN price is currently -69.43% below its historical high of $36.72

Price Analysts Target

$16.00
ELAN price is currently -29.84% lower than the consensus analysts' forecast

Price Today Change

+0.49%
ELAN price is up +0.49% today

Price YTD Change

-5.75%
ELAN price is down -5.75% since January 1st

Price 3-Year Change

-60.43%
ELAN price is down -60.43% over the past 3 years

Market cap

Market Cap

$5.55 B
ELAN market capitalization is $5.55 billion

Market Cap 3-Year Change

-58.64%
ELAN market capitalization is down -58.64% over the past 3 years

Market Cap All-time High

$17.37 B
ELAN market capitalization is currently -68.03% below its historical high of $17.37 billion

Market Cap Sector Rank

89.06%
ELAN market capitalization is higher than 89.06% of companies in Healthcare sector

Technical

Beta

1.07
ELAN beta is 1.07

200-day SMA

$13.80
ELAN price is currently -18.66% below its 200-day simple moving average

14-day RSI

44.48
ELAN 14-day relative strength index is 44.48

30-day Relative Volume

0.89
ELAN 30-day relative volume is 0.89

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$4.44 B
ELAN annual revenue is $4.44 billion

Annual Revenue Analysts Estimate

$4.49 B
ELAN annual revenue is currently -1.20% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+0.5%
ELAN annual revenue is up +0.5% year-on-year

Annual Revenue Sector Rank

91.48%
ELAN annual revenue is higher than 91.48% of companies in Healthcare sector

Profit

Annual Gross Profit

$2.44 B
ELAN annual gross profit is $2.44 billion

Annual Gross Margin

54.88%
ELAN annual gross profit margin is 54.88%

Annual Operating Profit

$251.00 M
ELAN annual operating income is $251.00 million

Annual Operating Margin

5.65%
ELAN annual operating profit margin is 5.65%

Annual Net Income

$338.00 M
ELAN annual net profit is $338.00 million

Annual Net Margin

7.61%
ELAN annual net profit margin is 7.61%

EPS

Annual EPS

$0.68
ELAN annual earnings per share is $0.68

Annual EPS Analysts Estimate

$0.86
ELAN annual earnings per share is currently -21.33% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+127.2%
ELAN annual earnings per share is up +127.2% year-on-year

Annual EPS Sector Rank

87.75%
ELAN annual earnings per share is higher than 87.75% of companies in Healthcare sector

ROA & ROE

Annual ROA

2.51%
ELAN annual return on assets is 2.51%

Annual ROE

5.49%
ELAN annual return on equity is 5.49%

EBIT & EBITDA

Annual EBIT

$723.00 M
ELAN annual earnings before interest & taxes is $723.00 million

Annual EBITDA

$1.39 B
ELAN annual EBITDA is $1.39 billion

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

16.75
ELAN price to earnings ratio is 16.75

PE Ratio Sector Rank

27%
ELAN price to earnings ratio is higher than 27% of companies in Healthcare sector

PB Ratio

PB Ratio

0.91
ELAN price to book ratio is 0.91

PB Ratio Sector Rank

40.48%
ELAN price to book ratio is higher than 40.48% of companies in Healthcare sector

PS Ratio

PS Ratio

1.25
ELAN price to sales ratio is 1.25

PS Ratio Sector Rank

29.56%
ELAN price to sales ratio is higher than 29.56% of companies in Healthcare sector

Enterprise value

Enterprise Value

$9.41 B
ELAN enterprise value is $9.41 billion

Enterprise Value Sector Rank

91.09%
ELAN enterprise value is higher than 91.09% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

6.79
ELAN EV/EBITDA is 6.79

EV/EBITDA Sector Rank

79.23%
ELAN EV/EBITDA is higher than 79.23% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.44
ELAN annual current ratio is 2.44

Annual Quick Ratio

1.25
ELAN annual quick ratio is 1.25

Leverage

Annual Debt To Equity

0.71
ELAN annual debt to equity ratio is 0.71

Annual Interest Coverage Ratio

3.08
ELAN annual interest coverage ratio is 3.08

Risk & Stability

Piotroski F-Score

7
ELAN piotroski f-score is 7

Altman Z-Score

1.02
ELAN altman z-score is 1.02

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$12.61 B
ELAN annual total assets is $12.61 billion

Annual Non Current Assets

$9.40 B
ELAN annual long term assets is $9.40 billion

Annual Current Assets

$3.21 B
ELAN annual total current assets is $3.21 billion

Annual Cash & Cash Equivalents

$468.00 M
ELAN annual cash & cash equivalents is $468.00 million

Equity

Annual Book Value

$6.10 B
ELAN annual book value is $6.10 billion

Annual Working Capital

$1.90 B
ELAN annual working capital is $1.90 billion

Liabilities

Annual Total Liabilities

$6.52 B
ELAN annual total liabilities is $6.52 billion

Annual Total Long Term Liabilities

$5.20 B
ELAN annual total long term liabilities is $5.20 billion

Annual Current Liabilities

$1.31 B
ELAN annual total current liabilities is $1.31 billion

Annual Accounts Payable

$296.00 M
ELAN annual accounts payable is $296.00 million

Debt

Annual Total Debt

$4.32 B
ELAN annual total debt is $4.32 billion

Annual Total Debt 1-Year Change

-25.16%
ELAN annual total debt is down -25.16% year-on-year

Annual Long Term Debt

$4.28 B
ELAN annual long term debt is $4.28 billion

Annual Short Term Debt

$44.00 M
ELAN annual short term debt is $44.00 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$4.19 B
ELAN annual total expenses is $4.19 billion

Annual Operating Expenses

$2.19 B
ELAN annual total operating expenses is $2.19 billion

Annual Cost Of Goods Sold

$2.00 B
ELAN annual cost of goods sold is $2.00 billion

Annual SGA

$1.31 B
ELAN annual SGA is $1.31 billion

Annual D&A

$662.00 M
ELAN annual depreciation & amortization is $662.00 million

Annual Interest Expense

$235.00 M
ELAN annual interest expense is $235.00 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$541.00 M
ELAN annual cash flow from operations is $541.00 million

Annual CFO 1-Year Change

+99.63%
ELAN annual cash flow from operations is up +99.63% year-on-year

Annual CFI

$1.16 B
ELAN annual cash flow from investing activities is $1.16 billion

Annual CFI 1-Year Change

+785.21%
ELAN annual cash flow from investing activities is up +785.21% year-on-year

Annual CFF

-$1.49 B
ELAN annual cash flow from financing activities is -$1.49 billion

Annual CFF 1-Year Change

-1697.59%
ELAN annual cash flow from financing activities is down -1697.59% year-on-year

Free CashFlow

Annual FCF

$380.00 M
ELAN annual free cash flow is $380.00 million

Annual FCF 1-Year Change

+224.79%
ELAN annual free cash flow is up +224.79% year-on-year

CAPEX

Annual CAPEX

$161.00 M
ELAN annual capital expenditures is $161.00 million

Annual CAPEX 1-Year Change

+4.55%
ELAN annual capital expenditures is up +4.55% year-on-year

Institutional Ownership

Similar stocks

INSP logo
Inspire Medical Systems (INSP)
OPCH logo
Option Care Health (OPCH)
ALKS logo
Alkermes (ALKS)
CYTK logo
Cytokinetics Incorporated (CYTK)
BLCO logo
Bausch Lomb (BLCO)
NUVL logo
Nuvalent (NUVL)
GH logo
Guardant Health (GH)
GRFS logo
Grifols SA (GRFS)
KRYS logo
Krystal Biotech (KRYS)

FAQ

  • What is the ticker symbol for Elanco Animal Health Incorporated?
  • Does Elanco Animal Health Incorporated pay dividends?
  • What sector is Elanco Animal Health Incorporated in?
  • What industry is Elanco Animal Health Incorporated in?
  • What country is Elanco Animal Health Incorporated based in?
  • When did Elanco Animal Health Incorporated go public?
  • Is Elanco Animal Health Incorporated in the S&P 500?
  • Is Elanco Animal Health Incorporated in the NASDAQ 100?
  • Is Elanco Animal Health Incorporated in the Dow Jones?
  • When was Elanco Animal Health Incorporated's last earnings report?
  • When does Elanco Animal Health Incorporated report earnings?
  • Should I buy Elanco Animal Health Incorporated stock now?

What is the ticker symbol for Elanco Animal Health Incorporated?

The ticker symbol for Elanco Animal Health Incorporated is NYSE:ELAN

Does Elanco Animal Health Incorporated pay dividends?

No, Elanco Animal Health Incorporated does not pay dividends

What sector is Elanco Animal Health Incorporated in?

Elanco Animal Health Incorporated is in the Healthcare sector

What industry is Elanco Animal Health Incorporated in?

Elanco Animal Health Incorporated is in the Drug Manufacturers - Specialty & Generic industry

What country is Elanco Animal Health Incorporated based in?

Elanco Animal Health Incorporated is headquartered in United States

When did Elanco Animal Health Incorporated go public?

Elanco Animal Health Incorporated's initial public offering (IPO) was on September 20, 2018

Is Elanco Animal Health Incorporated in the S&P 500?

No, Elanco Animal Health Incorporated is not included in the S&P 500 index

Is Elanco Animal Health Incorporated in the NASDAQ 100?

No, Elanco Animal Health Incorporated is not included in the NASDAQ 100 index

Is Elanco Animal Health Incorporated in the Dow Jones?

No, Elanco Animal Health Incorporated is not included in the Dow Jones index

When was Elanco Animal Health Incorporated's last earnings report?

Elanco Animal Health Incorporated's most recent earnings report was on Feb 25, 2025

When does Elanco Animal Health Incorporated report earnings?

The next expected earnings date for Elanco Animal Health Incorporated is May 8, 2025

Should I buy Elanco Animal Health Incorporated stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions